dihexa chemical properties solubility stability formulation (PNB-0408) | c-Met/HGFR Activator Solubility Enhancement of Dihydroquercetin via
Solubility Enhancement of Dihydroquercetin via Green Phase Modification Dihexa 1401708 83 5 BGC70883 Biosynth As part of its strategy to explore additional delivery systems for MEAI, Clearmind initiated formulation feasibility studies to evaluate the compound's suitability for intranasal administration. Initial work focused on evaluating MEAI's compatibility with dihexa chemical properties solubility stability ph formulation Physicochemical Factors Affecting Drug Absorption
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21


